Upadacitinib in active non-radiographic axial spondyloarthritis: 2-year data from the phase 3 SELECT-AXIS 2 study

Authors

Peter Wung
I. Lagunes-Galindo
Denis Poddubnyy (ORCID: https://orcid.org/0000-0002-4537-6015)
Filip Van den Bosch (ORCID: https://orcid.org/0000-0002-3561-5932)
Mitsumasa Kishimoto (ORCID: https://orcid.org/0000-0002-4007-1589)
Anna Shmagel (ORCID: https://orcid.org/0000-0002-1945-9255)
Tae-Hwan Kim
Xenofon Baraliakos (ORCID: https://orcid.org/0000-0002-9475-9362)
Walter P. Maksymowych (ORCID: https://orcid.org/0000-0002-1291-1755)
Koji Kato (ORCID: https://orcid.org/0000-0002-2606-5713)
Désirée van der Heijde
In-Ho Song
Atul A. Deodhar (ORCID: https://orcid.org/0000-0002-2130-1246)
Xianwei Bu

Institutions

University of Alberta (CA)
Oregon Health & Science University (US)
Kyorin University (JP)
Leiden University Medical Center (NL)
AbbVie (United States) (US)
Ghent University (BE)
Rheumazentrum Ruhrgebiet (DE)
VIB-UGent Center for Inflammation Research (BE)
Hanyang University Seoul Hospital (KR)
Charité - Universitätsmedizin Berlin (DE)
Ruhr University Bochum (DE)

Publication Details

Journal: Arthritis Research & Therapy
Published: 2025-02-04
DOI: https://doi.org/10.1186/s13075-024-03441-3
Citations: 7
Primary Topic: Spondyloarthritis Studies and Treatments
Type: article
Field-Weighted Citation Impact: 11.68

Funders

AbbVie

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Upadacitinib in active non-radiographic axial spondyloarthritis: 2-year data from the phase 3 SELECT-AXIS 2 study

Peter Wung, I. Lagunes-Galindo, Denis Poddubnyy, Filip Van den Bosch et al.

Feb 4, 2025

7 citations

Arthritis Research & Therapy

Spondyloarthritis Studies and Treatments

11.68

article

Upadacitinib in active non-radiographic axial spondyloarthritis: 2-year data from the phase 3 SELECT-AXIS 2 study

Peter Wung, I. Lagunes-Galindo, Denis Poddubnyy, Filip Van den Bosch, Mitsumasa Kishimoto, Anna Shmagel, Tae-Hwan Kim, Xenofon Baraliakos, Walter P. Maksymowych, Koji Kato, Désirée van der Heijde, In-Ho Song, Atul A. Deodhar, Xianwei Bu

February 4, 2025article en

7 citations

Abstract

No abstract available for this paper.

Arthritis Research & TherapyVol. 27(1)

University of Alberta (CA), Oregon Health & Science University (US), Kyorin University (JP), Leiden University Medical Center (NL), AbbVie (United States) (US), Ghent University (BE), Rheumazentrum Ruhrgebiet (DE), VIB-UGent Center for Inflammation Research (BE), Hanyang University Seoul Hospital (KR), Charité - Universitätsmedizin Berlin (DE), Ruhr University Bochum (DE)

AbbVie

Openalex Percentile: Top 1%

Spondyloarthritis Studies and Treatments

11.68

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Upadacitinib in active non-radiographic axial spondyloarthritis: 2-year data from the phase 3 SELECT-AXIS 2 study — Peter Wung, I. Lagunes-Galindo, et al. · Arthritis Research & Therapy (2025) | TGRS Research Map | TGRS